Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 361
Filter
1.
Article in Chinese | WPRIM | ID: wpr-1028889

ABSTRACT

The occurrence of Kaposi′s sarcoma (KS) is closely related to Kaposi′s sarcoma-associated herpesvirus (KSHV) infection of endothelial cells. KSHV infection can present as various types of KS, and clinical features, severity and prognosis differ among different types of KS. Classic KS is characterized by localized lesions and slow progression, AIDS-related KS and endemic KS are highly aggressive, and iatrogenic KS needs control of the primary disease during treatment. Therefore, individualized therapies should be developed according to the clinical classifications and characteristics of KS. This review summarizes treatment modalities of and research progress in KS.

2.
An. Fac. Med. (Perú) ; 84(3)sept. 2023.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1520000

ABSTRACT

Introducción. Una de las consecuencias psicológicas más frecuentes del COVID-19 es el miedo. Éste podría ocasionar una adherencia terapéutica no óptima y permitir la progresión de la enfermedad en personas con VIH. Objetivo. Evaluar la asociación entre el miedo a contraer COVID-19 y la adherencia al tratamiento antirretroviral en personas con VIH entre la tercera y cuarta ola epidémica de COVID-19 en el Perú. Métodos. Estudio transversal analítico en adultos con VIH del centro especializado Vía Libre enrolados por muestreo no probabilístico. Se empleó la escala Fear of COVID-19 Scale para medir el miedo a contraer COVID-19, y el cuestionario SMAQ para evaluar la adherencia terapéutica. Los resultados se presentaron de forma descriptiva, usando chi cuadrado para el análisis bivariado y modelos lineales generalizados familia Poisson para estimar razones de prevalencia crudas y ajustadas (RPa). Resultados. Entre febrero - julio del 2022, se enrolaron 149 personas con una mediana de edad de 35 años, el 91,3% fueron varones, y el 75,2% con carga viral indetectable. No se halló asociación entre el miedo a contraer COVID-19 y la adherencia terapéutica (RPa: 0,99; IC95%: 0,97 a 1,02). Adicionalmente, encontramos que las personas que presentaban alguna comorbilidad fueron 89% más adherentes que los que no las presentaban (RPa: 1,89; IC95%: 1,52 a 2,35). Conclusión. El miedo a contraer COVID-19 no se asoció a la adherencia al TARGA durante la tercera ola de pandemia en el Perú. Sin embargo, el presentar alguna comorbilidad se asoció a una adherencia terapéutica óptima. Se debe poner énfasis en los posibles factores que afecten la adherencia en personas con VIH durante la pandemia por COVID-19.


Introduction. One of the most frequent psychological consequences of COVID-19 is fear, which could lead to non-optimal therapeutic adherence and, therefore, to the disease progression. Objectives. To evaluate the possible association between the fear of contracting COVID-19 and adherence to antiretroviral therapy in persons with HIV during the period between the third and fourth epidemic wave of COVID-19 in Peru. Methods. Analytical cross-sectional study in adults with HIV from the specialized center "Vía Libre" enrolled by non-probabilistic sampling. The validated "Fear of COVID-19 Scale" was used to measure the fear of getting sick from COVID-19, and the "SMAQ" questionnaire to assess therapeutic adherence. Results were presented descriptively, using chi-square for bivariate analysis and generalized linear models, Poisson family to calculate crude and adjusted prevalence ratios (aPR). Results. Between February and July of 2022, 149 adults with a median age of 35 years were enrolled, 91.3% being male, and 75,2% had undetectable viral load levels. No association was found between fear of contracting COVID-19 and HAART adherence (aPR: 0,99; 95% CI 0,97 to 1,02). Persons with a comorbidity were 89% more adherent than persons withoutcomorbidities (RPa: 1,89; 95% CI 1,52 to 2,35). Conclusion. The fear of contracting COVID-19 was not associated with adherence to HAART during the third wave of COVID-19 pandemic in Peru. However, presenting a comorbidity was associated with optimal HAART adherence. Emphasis should be placed on potential factors affecting medication adherence in people with HIV during the COVID-19 pandemic.

3.
Article | IMSEAR | ID: sea-221890

ABSTRACT

Introduction: The knowledge of the effect of sociodemographic and disease-related factors on health-related quality of life (HRQoL) among people living with HIV/AIDS (PLWHA) is important for planning comprehensive health-care services for them. Material and Methods: Two hundred PLWHA on antiretroviral therapy (ART) volunteered to complete a self-reported World Health Organization’s Quality of Life?HIV brief questionnaire (WHOQoL-HIV-BREF) that examines six domains each with four items (physical, psychological, level of independence, social, environmental, and spiritual) with 25 facets and additional 5 facets specific to PLWHA (symptoms of HIV, social inclusion, forgiveness, worries about the future, and death and dying). Results: Only 135 questionnaires from 73 (53.3%) men and 63 (46.7%) women (male: female – 1.14:1) aged 20–82 years(mean ± standard deviation: 42.9 ± 10.5 years) were found complete. Eighty-five (63%) individuals were aged 41–60 years, 78 (57.8%) individuals were matriculates, graduates, or postgraduates, 76 (56.3%) respondents were married, and 38 (28.1%) were widows/widowers. Staying-alone workers comprised 43 (31.8%) individuals. Overall health and HRQoL were rated satisfactory (n = 85.2%) and good/very good (n = 74.8%) by a significantly greater number of individuals (P = 0.001). Pearson’s Chi-squared test showed no statistically significant (P > ?) associations between good HRQoL and variables such as age >40 years, gender, education, marital status, duration of disease, disclosure of serostatus to family, ART for >3 years, and CD4 >200 cells/mL. Conclusion: Regular ART can result in adequate control of immunosuppression and no comorbidities in a majority of PLWHA, family and social acceptance, and financial security can result in overall good HRQoL in all six domains within the WHOQoL-HIV-BREF. The study is limited by its cross-sectional study design and small sample size.

4.
Braz. j. otorhinolaryngol. (Impr.) ; Braz. j. otorhinolaryngol. (Impr.);89(3): 425-431, May-June 2023. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1447711

ABSTRACT

Abstract Objectives This study aimed to assess the prevalence of oral lesions in patients living with HIV infection and their association with CD4 count, viral load, and antiretroviral therapy in patients with HIV. Methods A cross-sectional study was conducted on a sample of 161 patients attending the… All the patients were examined for their oral lesions, current CD4 counts, type, and duration of the therapy. Data analyses were carried out using Chi-Square, Student T/Mann-Whitney, and logistic regression tests. Results Oral lesions were observed in 58.39% of patients with HIV. Periodontal disease with 78 (48.45%) or without mobility 79 (49.07%) was observed more frequently, followed by hyperpigmentation of oral mucosa 23 (14.29%), Linear Gingival Erythema (LGE) 15 (9.32%), candidiasis pseudomembranous 14 (8.70%). Oral Hairy Leukoplakia (OHL) was observed only in 3 (1.86%). A relationship between periodontal disease with dental mobility and smoking was found (p = 0.04), as well duration of treatment (p = 1.53e-3) and age (p = 0.02). Hyperpigmentation was related to race (p = 0.01) and smoking (p = 1.30e-6). CD4 count, CD4:CD8 ratio, viral load, or type of treatment were not associated with oral lesions. Logistic regression showed that the duration of treatment has a protective effect on the periodontal disease with dental mobility (OR = 0.28 [−2.27 to −0.25]; p-value = 0.03), independent of age or smoking. To hyperpigmentation, the best model included smoking (OR = 8.47 [1.18-3.10], p = 1.31e-5), without race or type and duration of treatment. Conclusion Among HIV patients undergoing antiretroviral treatment, oral lesions can be observed, predominantly periodontal disease. Pseudomembranous candidiasis and oral hairy leukoplakia were also observed. No relationship was found between associated oral manifestations in HIV patients and the start of the treatment, TCD4+ and TCD8+ cell count, TCD4:TCD8 ratio, or viral load. The data indicate that there is a protective effect of duration of treatment with relation to periodontal disease with mobility and that hyperpigmentation seems to be more related to smoking than type and duration of treatment. Level of evidence Level 3 (OCEBM Levels of Evidence Working Group*. "The Oxford 2011 Levels of Evidence").

5.
Rev. cienc. salud (Bogotá) ; 21(1): 1-17, ene.-abr. 2023.
Article in English | LILACS | ID: biblio-1427745

ABSTRACT

Aim: To adapt and validate an existing instrument to assess the barriers to antiretroviral treatment adherence among individuals with hiv in Córdoba, Argentina. Materials and methods: The final sample population included 180 Argentinian people. The mean age of the participants was 40.61 (sd = 12.032) years and 82.8% were men. Various internal structure and reliability and validity studies with other variables were conducted on the study population (n = 180). Results: The results of confirmatory factor analysis were consistent with the factorial structure of the original study. However, to achieve this, items that had low factorial loads and were redundant had to be eliminated. Coefficient ω values of .833 on the Information sub-scale, .759 on the Motivation subscale, and .888 on the Behavioral Skills subscale were obtained. Significant correlations were determined between the results of adherence and barriers to treatment. Conclusion: The results suggest that the instrument can be used to assess the barriers to antiretroviral treatment adherence in Córdoba, Argentina. Although further research is warranted, these results are promising.


adaptar y validar un instrumento para evaluar barreras a la adherencia antirretroviral en personas que conviven con el vih en Córdoba (Argentina). Materiales y métodos: la muestra final incluyó 180 participantes argentinos. La media de edad fue de 40.61 (de = 12.032) y el 82.8 % fueron hombres. Sobre la muestra (n = 180) se efectuaron estudios de estructura interna, confiabilidad y validez con otras variables. Resultados: el análisis factorial confirmatorio arrojó resultados congruentes con la estructura factorial del estudio original, aunque para ello fue necesario eliminar ciertos ítems que presentaban bajas cargas factoriales y que pueden ser representados por otros ítems, debido a información redundante. Se obtuvieron coeficientes ω = 0.833 en la subescala información; ω = 0.759 en la subescala motivación, y ω = 0.888 en la subescala habilidades comportamentales. Se encontraron correlaciones significativas entre los resultados de adherencia al tratamiento y barreras al tratamiento. Conclusión: aunque se requieren de mayores investigaciones, los resultados son promisorios, sugieren que el instrumento puede usarse para evaluar barreras de la adherencia al tratamiento antirretroviral en Córdoba.


adaptar e validar um instrumento de barreiras à adesão anti-retroviral em pessoas vivendo com hivem Córdoba, Argentina. Materiais e métodos: A amostra final incluiu 180 participantes argentinos. A idade média era de 40,61 anos (sd = 12,032) e 82,8% eram homens. Com a amostra (n = 180) foram realizados estudos de estrutura interna, confiabilidade e validade com outras variáveis. Resultados: a análise fatorial confirma-tória apresentou resultados adequados com a estrutura fatorial do estudo original, embora para isso tenha sido necessário eliminar alguns itens que apresentavam baixas cargas fatoriais e poderiam ser representados por outros itens devido a informações redundantes. Os coeficientes ω = 0,833 foram obtidos na subescala informação; ω = 0,759 na subescala motivação, y ω = 0,888 na subescala competências comportamentais. Correlações significativas foram encontradas entre os resultados do adherencia al tratamiento e do barreiras à adesão ao tratamento. Conclusão: embora mais pesquisas sejam necessárias, os resultados são promissores, sugerindo que o instrumento pode ser usado para avaliar as barreiras à adesão ao tratamento anti-retroviral em Córdoba, Argentina.


Subject(s)
Humans , Psychometrics , Research , Therapeutics , Reproducibility of Results , HIV , Methods
6.
China Pharmacy ; (12): 2620-2624, 2023.
Article in Chinese | WPRIM | ID: wpr-997796

ABSTRACT

OBJECTIVE To investigate the occurrence time and risk factors of anemia in patients with acquired immune deficiency syndrome (AIDS) after taking highly active antiretroviral therapy (HAART) containing zidovudine. METHODS The clinical data of 2 150 AIDS patients who were followed up in the care clinic of Liuzhou People’s Hospital from January 1, 2010 to December 31, 2022 were collected. The occurrence time of anemia was analyzed retrospectively, and the risk factors of anemia were analyzed by univariate analysis and binary Logistic regression analysis. RESULTS A total of 854 AIDS patients receiving HAART containing zidovudine were collected, and 107 patients (12.53%) developed anemia. Most of them (63.55%) developed anemia within 3 months after treatment. Baseline hemoglobin [OR=2.944, 95%CI (1.195, 7.501), P=0.019], baseline CD4+ T lymphocyte count [OR=2.472, 95%CI (1.117, 5.469), P=0.026] and baseline human immunodeficiency virus-ribonucleic acid (HIV-RNA) [OR=4.299, 95%CI (1.905, 9.705), P<0.001] was associated with anemia. CONCLUSIONS The median time of anemia in AIDS patients receiving HAART containing zidovudine is the second month after initiation of treatment. Baseline hemoglobin≤110 g/L, baseline CD4+ T lymphocyte E-mail:1315775863@qq.com count≤100 /mm3, and baseline HIV-RNA≥100 000 copies/mL are independent risk factors for anemia in these patients.

7.
Journal of Integrative Medicine ; (12): 332-353, 2023.
Article in English | WPRIM | ID: wpr-982687

ABSTRACT

Acquired immune deficiency syndrome (AIDS) is a worldwide epidemic caused by human immunodeficiency virus (HIV) infection. Newer medicines for eliminating the viral reservoir and eradicating the virus are urgently needed. Attempts to locate relatively safe and non-toxic medications from natural resources are ongoing now. Natural-product-based antiviral candidates have been exploited to a limited extent. However, antiviral research is inadequate to counteract for the resistant patterns. Plant-derived bioactive compounds hold promise as powerful pharmacophore scaffolds, which have shown anti-HIV potential. This review focuses on a consideration of the virus, various possible HIV-controlling methods and the recent progress in alternative natural compounds with anti-HIV activity, with a particular emphasis on recent results from natural sources of anti-HIV agents. Please cite this article as: Mandhata CP, Sahoo CR, Padhy RN. A comprehensive overview on the role of phytocompounds in human immunodeficiency virus treatment. J Integr Med. 2023; 21(4):332-353.


Subject(s)
Humans , HIV , HIV Infections/drug therapy , Anti-HIV Agents/therapeutic use
8.
Article in Chinese | WPRIM | ID: wpr-1026935

ABSTRACT

Objective:To explore the relationship between drug resistance occurrence and the distribution pattern of polymorphic loci in individuals with human immunodeficiency virus infection/acquired immunodeficiency syndrome (HIV/AIDS) treated with highly active anti-retroviral therapy (HAART).Methods:HAART-failed HIV/AIDS patients who successfully amplified the gene sequences of the pol region between June 2015 and December 2021 from 16 prefecture-level administrative regions in Yunnan Province were included.The resistant sequences were classified using the human immunodeficiency virus (HIV) basic local alignment search tool (BLAST) and validated through MEGA 6.0, and the obtained sequences were submitted to the Stanford University HIV Drug Resistance Database to identify drug resistance loci. The distribution of polymorphic loci was analyzed across patients exhibiting varying degrees of drug resistance, different treatment regimens and distinct HIV-1 subtypes.Changes of the frequencies of polymorphic loci in patients with different degrees of drug resistance were analyzed using trend chi-square test. Statistical comparisons and further paired comparisons were performed using chi-square test.Results:Gene sequences were amplified from 1 453 patients, and the resistance testing results showed 954 sensitive, 224 potentially or low resistant, 189 moderately resistant, and 86 highly resistant patients. The frequencies of mutations I15V, L19I, D60E in the HIV-1 protease region (PR region) and E36A, T39D, S48T mutations in the HIV-1 reverse transcriptase region (RT region) showed a decreasing trend as the degree of HIV-1 resistance escalated ( χ2trend=19.86, 9.16, 13.66, 37.64, 18.44 and 40.86, respectively, all P<0.01). Conversely, the mutations V77I in the PR region and K122E in the RT region showed an ascending trend ( χ2trend=12.19 and 10.03, respectively, both P<0.01). Distinct treatment groups, namely zidovudine (AZT)+ lamivudine (3TC)+ lopinavir/ritonavir (LPV/r), AZT+ 3TC+ efavirenz (EFV), AZT+ 3TC+ nevirapine (NVP), and tenofovir (TDF)+ 3TC+ EFV, were examined. Statistically significant differences in the frequencies of mutations E35D, M36I, and D60E in the PR region, as well as S48T, K122E, and R211K in the RT region, were observed among these treatment groups ( χ2=22.46, 9.32, 14.46, 26.85, 18.92 and 24.26, respectively, all P<0.05). In paired comparisons, AZT+ 3TC+ LPV/r group displayed higher frequencies of E35D, M36I, and D60E mutations, the AZT+ 3TC+ EFV group showed a higher frequency of S48T mutation, the AZT+ 3TC+ NVP group showed a higher frequency of K122E mutation, and the TDF+ 3TC+ EFV group exhibited a higher frequency of R211K mutation, all with statistically significant differences (all P<0.008). The differences in the frequencies of T12S, I15V, L19I, M36I, V77I, L89M in the PR region and E53D, I135V, S162C, R211K, K277R in the RT region among circulating recombinant form (CRF)08_BC, CRF07_BC and CRF01_AE subtype group were statistically significant ( χ2=693.60, 712.51, 798.11, 434.85, 386.91, 657.78, 932.58, 409.21, 344.39, 469.44 and 260.48, respectively, all P<0.001). In paired comparisons, the frequencies of T12S, I15V, L19I, E53D, I135V, S162C and R211K in CRF08_BC subtype, the frequencies of V77I and K277R in CRF07_BC subtype, and the frequencies of M36I and L89M in CRF01_AE subtype were higher than those in the other two groups, and the differences were all statistically significant (all P<0.017). Conclusions:The polymorphic loci resulting from HIV-1 HAART failure show different distribution patterns across various degrees of drug resistance, treatment regimens and HIV-1 subtypes.These loci demonstrate both specific and shared characteristics. It is necessary to enhance the surveillance of select polymorphic loci.

9.
Article in Chinese | WPRIM | ID: wpr-972775

ABSTRACT

ObjectiveTo investigate the risk factors of anemia in HIV-infected patients receiving highly active antiretroviral therapy (HAART) in the Pudong New Area. MethodsA retrospective cohort study was conducted among HIV-infected patients who started HAART from 2005 to 2020 in Pudong New Area. Cox proportional hazards model was used to analyze the risk factors of anemia, moderate or severe anemia, and chronic anemia. The piecewise linear mixed-effect model was used to analyze the association between initial HAART classes and hemoglobin change in the follow-up. ResultsA total of 2 403 HIV-infected patients were included in the analysis. Among them, there were 357 cases of new onset anemia, 86 cases of chronic anemia and 102 cases of moderate or severe anemia, with the incidence density of 4.41/100 person years, 0.89/100 person years and 0.96/100 person years respectively. Multifactorial Cox regression analysis results showed that female, age >45 years, baseline CD4+ T lymphocyte count (CD4) <200 cells‧μL-1, opportunistic infections, glomerular filtration rate (eGFR) <60 mL‧min-1‧(1.73 m2)-1, and zidovudine (AZT) or protease inhibitor (PIs) based regimens were associated factors for the development of anemia. Female, age >45 years, CD4 <200 cells‧μL-1, opportunistic infections, and AZT-based regimens were associated with the development of chronic anemia. Mild anemia at baseline and AZT-based regimens were associated with the development of moderate or severe anemia. Linear mixed-effects model showed that the use of AZT (-7.87 g‧L-1, 95%CI: -9.42 to -6.32) or PIs (-3.43 g‧L-1, 95%CI: -5.57 to -1.30) was associated with lower Hb at follow-up. ConclusionInitial use of AZT and PIs is associated with progression to anemia and a lower follow-up hemoglobin level. Increased hemoglobin monitoring in users of AZT and PIs may be beneficial, especially during the first 6 months after initiation of HAART.

10.
RGO (Porto Alegre) ; 71: e20230017, 2023. tab
Article in English | LILACS-Express | LILACS, BBO | ID: biblio-1449024

ABSTRACT

ABSTRACT The therapeutic management, as well as the HIV virus itself, has been associated with alterations at the bone level, which may also have a relationship with the maxillomandibular alveolar processes and potential development of periodontal diseases, especially periodontitis. Objective: The objective of this study was to evaluate the periodontal health condition of young adults living with HIV/AIDS, through the measurement of the Periodontal Clinical Insertion Level (CAL) and to raise general data on the health conditions facing HIV and on the quality of life of this audience. Methods: Data were collected at a Reference Center for STI/AIDS in São Paulo - SP, Brazil. The method used was guided by previously validated indicators. In total, 31 individuals aged between 20 and 24 years, both genders and using TAAP were evaluated. For the analyses, the Excel Microsoft® software was used. Results: There was a prevalence of periodontitis in the assessed public of 45.17%. In view of the quality of life, the public was classified as "Regular" and no cases of Necrozing Periodontitis were observed, which is strongly associated with HIV infection. Conclusions: The evaluated public showed a high prevalence of periodontitis, which reinforces the importance of Dentistry in monitoring People Living with HIV/AIDS, in order to prevent the worsening of periodontal diseases.


RESUMO O manejo terapêutico, bem como o próprio vírus do HIV tem sido associados à quadros de alterações em nível ósseo, podendo ter uma relação também com os processos alveolares maxilo-mandibulares e potencial desenvolvimento de quadros de doenças periodontais, em especial a periodontite. Objetivo: O objetivo do trabalho foi avaliar a condição da saúde periodontal de indivíduos adultos jovens vivendo com HIV/AIDS, por meio da aferição do Nível de Inserção Clínica Periodontal e levantar dados gerais sobre as condições de saúde frente ao HIV e sobre a qualidade de vida desse público. Os dados foram coletados em um Centro de Referência em IST/AIDS de São Paulo - SP, Brasil. Métodos: O método empregado teve como guia norteadora indicadores previamente validados. No total, foram avaliados 31 indivíduos com idades entre 20 e 24 anos, ambos os gêneros e em uso da terapia antirretroviral. Para as análises foi utilizado o software Excel Microsoft®. Resultados: Foi observado uma prevalência de periodontite no público avaliado de 45,17%. Frente a qualidade de vida o público foi classificado como "Regular" e não foi observado quadros de Periodontite Necrozante, que está fortemente associado a infecção pelo HIV. Conclusão: O público avaliado apresentou alta prevalência de periodontite, o que reforça a importância da Odontologia no acompanhamento das Pessoas Vivendo com HIV/Aids, no sentido de prevenir o agravamento dos quadros de doenças periodontais.

11.
Article in Spanish | LILACS-Express | LILACS, BDENF | ID: biblio-1528282

ABSTRACT

Objetivo: Comprender las experiencias de mujeres transgénero con VIH que viven con síntomas asociados al tratamiento antirretroviral en Bucaramanga. Material y Método: se realizó un estudio fenomenológico basado en el método de Colaizzi durante los meses de febrero a marzo de 2022; los participantes fueron invitados a contribuir en el estudio por intermedio de una madre transgénero, contactada a través de una red comunitaria; se utilizó un muestreo de "bola de nieve"; el primer contacto se realizó de manera telefónica con cada una de las posibles participantes, verificando los criterios de inclusión; se realizaron entrevistas a profundidad y la saturación teórica se dio al realizar la séptima entrevista, pero se decidió completar 10 entrevistas para ampliar el análisis. Resultados: Se identificaron 5 unidades temáticas: cerrando los ojos a la verdad, experimentado expresiones negativas, entre el ir y venir de los síntomas, generando estrategias para el control de síntomas y renaciendo a una nueva vida. Conclusiones: En las mujeres transgénero, la experiencia de síntomas asociados al tratamiento antirretroviral, es un proceso difícil, pero se posibilita por el apoyo en el control de síntomas y el apoyo familiar y social.


Objective: To understand the experiences of HIV-positive transgender women living with antiretroviral treatment-related symptoms in Bucaramanga, Colombia. Material and Method: A phenomenological study was conducted based on Colaizzi's, between February and March 2022; participants were invited to contribute to the study through a Transgender mother, contacted through a community network; a snowball sampling method was used, the initial contact was made via telephone with each potential participant, verifying inclusion criteria; in-depth interviews were conducted and theoretical saturation was achieved after the seventh interview, but it was decided to complete 10 interviews to further expand the analysis. Results: Five thematic units were identified: closing eyes to the truth, experiencing negative expressions, the coming and going of symptoms, generating strategies for symptom control, and rebirth to a new life. Conclusion: Among transgender women, the experience of symptoms associated with antiretroviral treatment is a difficult process, but is made possible by symptom management support, as well as family and social support.


Objetivo: Compreender as vivências de mulheres transgênero com HIV que convivem com sintomas associados ao tratamento antirretroviral em Bucaramanga, Colômbia. Material e Método: Foi realizado um estudo fenomenológico baseado no método de Colaizzi durante os meses de fevereiro a março de 2022; os participantes foram convidados a contribuir para o estudo através de uma mãe transgênero, contactada através de uma rede comunitária; foi utilizada amostragem "bola de neve"; o primeiro contato foi feito por telefone com cada um dos possíveis participantes, verificando os critérios de inclusão; foram realizadas entrevistas em profundidade e a saturação teórica ocorreu quando foi realizada a sétima entrevista, mas optou-se por realizar 10 entrevistas para ampliar a análise. Resultados: Foram identificadas cinco unidades temáticas: fechar os olhos para a verdade, vivenciar expressões negativas, o ir e vir dos sintomas, gerar estratégias para o controle dos sintomas e renascer para uma nova vida. Conclusão: Entre as mulheres transgênero, a experiência dos sintomas associados ao tratamento antirretroviral é um processo difícil, mas que é possível graças ao apoio na gestão dos sintomas e ao apoio familiar e social.

12.
Acta Paul. Enferm. (Online) ; 36: eAPE01712, 2023. tab, graf
Article in Portuguese | LILACS-Express | BDENF, LILACS | ID: biblio-1439037

ABSTRACT

Resumo Objetivo Analisar as produções científicas acerca da eficácia de intervenções utilizando a entrevista motivacional para adesão à terapia antirretroviral por pessoas com o vírus da imunodeficiência humana. Métodos Revisão sistemática realizada em quatro bases de dados, o MEDLINE, CINAHL, IBECS, LILACS, e em uma biblioteca eletrônica, a SciELO, sem restrição de idioma, data e tamanho amostral. O levantamento de artigos foi realizado em setembro de 2021, utilizando-se os descritores Motivational Interviewing, HIV, Acquired Immunodeficiency Syndrome e Antiretroviral Therapy, Highly Active. Foram incluídos artigos do tipo ensaio clínico randomizado, com amostra de pessoas com vírus da imunodeficiência humana maiores de 18 anos, e excluídas pesquisas envolvendo crianças, adolescentes e gestantes. Dez artigos foram selecionados e analisados quanto ao rigor e características de cada estudo. Resultados A entrevista motivacional foi aplicada presencialmente e associada à chamada telefônica, visita domiciliar, fitas de áudio, encartes informativos, aconselhamento, teorias cognitivas-comportamentais e cognitivas-sociais. Os estudos incluídos nesta revisão evidenciaram que as intervenções utilizando a entrevista motivacional aumentaram a adesão aos antirretrovirais por pessoas com vírus da imunodeficiência humana. Conclusão O estudo contribuiu para identificar os dados existentes sobre a eficácia de intervenções com a entrevista motivacional, com foco na adesão à terapia antirretroviral por pessoas com vírus da imunodeficiência humana, tornando visíveis os pontos que precisam ser aprofundados e mostrando a importância desta estratégia, que pode ser utilizada pelos enfermeiros e demais profissionais de saúde, visando o bem-estar dos pacientes. International Prospective Register Systematic Reviews: CRD42019123724


Resumen Objetivo Analizar las producciones científicas sobre la eficacia de las intervenciones que utilizan la entrevista motivacional para la adhesión al tratamiento antirretroviral de personas con el virus de la inmunodeficiencia humana. Métodos Revisión sistemática realizada en cuatro bases de datos, MEDLINE, CINAHL, IBECS, LILACS, y en una biblioteca electrónica, SciELO, sin restricción de idioma, fecha, ni tamaño de la muestra. La recopilación de archivos fue realizada en septiembre de 2021, con los descriptores Motivational Interviewing, HIV, Acquired Immunodeficiency Syndrome y Antiretroviral Therapy, Highly Active. Se incluyeron artículos tipo ensayo clínico aleatorizado, con muestreo de personas con virus de la inmunodeficiencia humana mayores de 18 años; y se excluyeron estudios que incluían niños, adolescentes y mujeres embarazadas. Se seleccionaron diez artículos y se analizó el rigor y características de cada estudio. Resultados La entrevista motivacional se realizó presencialmente y estuvo relacionada con llamadas telefónicas, visitas domiciliares, cintas de audio, suplementos informativos, asesoramiento, teorías cognitivas conductuales y cognitivas sociales. Los estudios incluidos en esta revisión evidenciaron que las intervenciones que utilizan la entrevista motivacional aumentaron la adhesión a los antirretrovirales de personas con el virus de la inmunodeficiencia humana. Conclusión El estudio ayudó a identificar los datos existentes sobre la eficacia de intervenciones con entrevistas motivacionales, con énfasis en la adhesión al tratamiento antirretroviral de personas con el virus de la inmunodeficiencia humana, se visibilizaron los puntos en los que es necesario profundizar y se mostró la importancia de esta estrategia, que puede ser utilizada por enfermeros y demás profesionales de la salud, para el bienestar de los pacientes.


Abstract Objective To analyze scientific productions about the effectiveness of interventions using motivational interviewing for adherence to antiretroviral therapy by people with the human immunodeficiency virus. Methods This is a systematic review carried out in four databases, MEDLINE, CINAHL, IBECS, LILACS, and in an electronic library, SciELO, without language, date and sample size restrictions. The survey of articles was carried out in September 2021, using the descriptors Motivational Interviewing, HIV, Acquired Immunodeficiency Syndrome and Antiretroviral Therapy, Highly Active. Randomized clinical trial articles were included, with a sample of people with human immunodeficiency virus over 18 years old, and research involving children, adolescents and pregnant women was excluded. Ten articles were selected and analyzed regarding the rigor and characteristics of each study. Results Motivational interviewing was applied in person and associated with a telephone call, home visit, audio tapes, informational inserts, counseling, cognitive-behavioral and cognitive-social theories. The studies included in this review showed that interventions using motivational interviewing increased adherence to antiretrovirals by people with human immunodeficiency virus. Conclusion The study contributed to identify existing data on the effectiveness of interventions with motivational interviewing, focusing on adherence to antiretroviral therapy by people with human immunodeficiency virus, making visible the points that need to be deepened and showing the importance of this strategy, which can be used by nurses and other health professionals, aiming at patients' well-being.International Prospective Register Systematic Reviews: CRD42019123724

13.
Acta Paul. Enferm. (Online) ; 36: eAPE03101, 2023. tab, graf
Article in Portuguese | LILACS-Express | LILACS, BDENF | ID: biblio-1419842

ABSTRACT

Resumo Objetivo Avaliar a efetividade de uma cartilha educativa para promoção do estilo de vida saudável e adesão aos antirretrovirais em pessoas com HIV. Métodos Ensaio clínico randomizado em ambulatório de Fortaleza, Ceará, Brasil, com 70 pacientes no grupo intervenção e 74 no controle. Critérios de inclusão: pessoas com HIV maiores de 18 anos, de ambos os sexos, em terapia antirretroviral por mais de seis meses, ter telefone fixo ou celular, e 35 ou mais pontos na Escala de Letramento em Saúde. A coleta de dados ocorreu em quatro momentos, utilizando-se a Escala de Perfil do Estilo de Vida Individual e o Questionário para Avaliação da Adesão ao Tratamento Antirretroviral. O grupo controle recebeu a consulta médica de rotina, e o grupo intervenção, além da consulta de rotina, realizou a leitura da cartilha em consultório, e depois levou-a para o domicílio. Na estatística, utilizou-se análise de variância não paramétrica de medidas repetidas. Resultados A maioria dos participantes tinha estilo de vida insatisfatório na avaliação basal. A cartilha melhorou o estilo de vida dos pacientes após dois (P<0,001), quatro (P<0,001) e seis meses (P<0,001) da intervenção, quando comparados os diferentes tempos ao valor basal e ao controle. Houve melhora dos escores de adesão aos antirretrovirais no grupo intervenção quando comparado à linha de base (P<0,001) e ao controle (P<0,001). Conclusão A cartilha foi efetiva para promover estilo de vida saudável e melhorar a adesão aos antirretrovirais em pessoas com HIV, portanto, pode complementar as consultas ambulatoriais. Registro Brasileiro de Ensaios Clínicos (ReBEC): RBR-7p6vsr


Resumen Objetivo Evaluar la efectividad de una cartilla educativa para la promoción del estilo de vida saludable y adhesión a los antirretrovirales para personas con VIH. Métodos Ensayo clínico aleatorizado en consultorios externos de Fortaleza, estado de Ceará, Brasil, con 70 pacientes en el grupo experimental y 74 en el de control. Criterios de inclusión: personas con VIH mayores de 18 años, de ambos sexos, en tratamiento antirretroviral por más de seis meses, con teléfono fijo o celular y con 35 puntos o más en la Escala de Alfabetización en Salud. La recolección de datos se realizó en cuatro momentos, mediante la Escala de Perfil del Estilo de Vida y el Cuestionario para la Evaluación de la Adhesión al Tratamiento Antirretroviral. El grupo de control recibió una consulta médica de rutina, y el grupo experimental, además de la consulta de rutina, leyó la cartilla en el consultorio y después se la llevó a su casa. En la estadística, se usó el análisis de varianza no paramétrico de medidas repetidas. Resultados La mayoría de los participantes tenía un estilo de vida insatisfactorio en la evaluación de base. La cartilla mejoró el estilo de vida de los pacientes después de dos (P<0,001), cuatro (P<0,001) y seis meses (P<0,001) de la intervención, si se lo compara con los diferentes tiempos al valor de base y al control. Se observó una mejora de la puntuación de adhesión a los antirretrovirales en el grupo experimental si se lo compara con la línea de base (P<0,001) y con el control (P<0,001). Conclusión La cartilla fue efectiva para promover un estilo de vida saludable y mejorar la adhesión a los antirretrovirales en personas con VIH; por lo tanto, puede complementar las consultas de los consultorios externos.


Abstract Objective To assess the effectiveness of an educational booklet to promote healthy lifestyle and antiretroviral compliance in people with HIV. Methods This is a randomized clinical trial at an outpatient clinic in Fortaleza, Ceará, Brazil, with 70 patients in the intervention group and 74 in the control group. People with HIV over 18 years of age, of both sexes, on antiretroviral therapy for more than six months, with a landline or cell phone, and 35 or more points on the Health Literacy Scale were included. Data collection took place in four moments, using the Individual Lifestyle Profile Scale and the Assessment of Antiretroviral Therapy Compliance Questionnaire (Cuestionario para la Evaluación de la Adhesión al Tratamiento Antirretroviral). The control group received routine medical consultation, and the intervention group, in addition to routine consultation, read the booklet in the office, and then took it home. Non-parametric analysis of variance of repeated measures was used for statistics. Results Most participants had an unsatisfactory lifestyle at baseline. The booklet improved patients' lifestyle after two (P<0.001), four (P<0.001) and six months (P<0.001) of intervention, when comparing the different times to baseline and control. There was an improvement in antiretroviral compliance scores in the intervention group when compared to baseline (P<0.001) and control (P<0.001). Conclusion The booklet was effective in promoting a healthy lifestyle and improving antiretroviral compliance in people with HIV, therefore, it can complement outpatient consultations. Brazilian Clinical Trial Registry (ReBEC): RBR-7p6vsr

14.
Cad. Saúde Pública (Online) ; 39(1): e00099622, 2023. tab, graf
Article in Portuguese | LILACS-Express | LILACS | ID: biblio-1421017

ABSTRACT

A adesão à terapia antirretroviral (TARV) é fundamental para obter o controle da infecção por HIV, evitando complicações clínicas e o desenvolvimento de cepas de HIV resistentes. Vários municípios brasileiros estão comprometidos com a meta 90-90-90, que prevê que 90% dos casos de HIV/aids sejam diagnosticados, que 90% destes estejam em tratamento e, destes, 90% alcancem a supressão viral. Entretanto, existem apenas três estudos brasileiros que avaliam a adesão à TARV a partir de dados secundários de dispensação. Este estudo objetivou estimar a prevalência de adesão ao tratamento no Município de Florianópolis, Santa Catarina, Brasil, examinando sua associação com aspectos demográficos, de utilização de saúde e características clínicas. Realizou-se um estudo transversal com o uso de dados secundários do prontuário eletrônico e dados nacionais, dos Sistema de Controle Logístico de Medicamentos (SICLOM) e Sistema de Controle de Exames Laboratoriais (SISCEL), de pessoas vivendo com HIV/aids no município de abril de 2020 a março de 2021. A prevalência de adesão à TARV foi de cerca de 85%. Pessoas brancas, do sexo masculino, que tinham acompanhamento tanto na atenção primária à saúde (APS) quanto na atenção secundária tinham maior adesão ao tratamento. A idade e o número de consultas apresentaram associação direta com adesão à TARV. O processo de descentralização do cuidado ao usuário vivendo com HIV/aids é o caminho para uma assistência mais integral, porém desafios técnicos e éticos ainda precisam ser enfrentados. A qualificação profissional, o correto referenciamento com articulação em rede e a atenção às questões de sigilo e confidencialidade precisam ser reforçadas de forma a ampliar a adesão ao tratamento.


Adherence to antiretroviral therapy (ART) is essential to control HIV infections and avoid clinical complications and the development of resistant HIV strains. Several Brazilian municipalities have committed themselves to the 90-90-90 target, which aims at diagnosing 90% of HIV/AIDS cases, treating 90% of them, and virally suppressing 90% of them. However, only three Brazilian studies have assessed adherence to ART from secondary dispensing data. This study aimed to estimate the prevalence of adherence to treatment in the Municipality of Florianópolis, Santa Catarina State, Brazil, examining its association with demographic, health access, and clinical characteristics. A cross-sectional study was conducted using secondary national data from electronic medical records and Medication Logistic Control System (SICLOM) and Laboratory Test Control System (SISCEL) regarding people living with HIV/AIDS in the municipality from April 2020 to March 2021. We found an about 85% prevalence of adherence to ART. White men with follow-ups both in primary and secondary care showed greater adherence to treatment. Age and number of consultations directly related to adherence. Decentralizing care for users living with HIV/AIDS is the way to more comprehensive care but technical and ethical challenges still require solutions. Professional training, correct network referrals, and attention to confidentiality issues must be reinforced to expand treatment adherence.


La adherencia a la terapia antirretroviral (TARV) es fundamental para controlar la infección por VIH, evitando complicaciones clínicas y el desarrollo de cepas de VIH resistentes. Varios municipios brasileños están comprometidos con la meta 90-90-90, que estima el diagnóstico del 90% de los casos de VIH/SIDA, que el 90% de estos reciban tratamiento y, de estos, el 90% logran llegar a la supresión viral. Sin embargo, solo hay tres estudios brasileños que evalúan la adherencia al TARV con base en datos secundarios sobre la dispensación. Este estudio tuvo por objetivo estimar la prevalencia de adherencia al tratamiento en la ciudad de Florianópolis, Santa Catarina, Brasil y su asociación con aspectos demográficos, uso de la salud y características clínicas. Se realizó un estudio transversal con los datos secundarios de la historia clínica electrónica y los datos nacionales del Sistema de Control Logístico de Medicamentos (SICLOM) y Sistema de Control de Pruebas de Laboratorio (SISCEL) de las personas que viven con VIH/SIDA en ese municipio en el período de abril de 2020 a marzo de 2021. La prevalencia de adherencia al TARV fue casi del 85%. Las personas de raza blanca, del sexo masculino, que recibían seguimiento en la atención primaria o en la atención secundaria tuvieron mayor adherencia al tratamiento. La edad y el número de consultas se asociaron directamente con la adherencia al TARV. El proceso de descentralización de la atención a los usuarios que viven con VIH/SIDA y sida es la forma de brindar una atención más integral, pero aún se deben enfrentar desafíos técnicos y éticos. Es necesario mejorar la calificación profesional, la correcta derivación con articulación en red y tener cuidado al secreto y la confidencialidad para que se intensifique aún más la adherencia al tratamiento.

15.
Einstein (São Paulo, Online) ; 21: eRW0231, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1440070

ABSTRACT

ABSTRACT Introduction The human immunodeficiency virus (HIV) pandemic remains an important issue. In 2020, approximately 37.7 million people were living with the disease and there were more than 680 thousand deaths due to complications linked to the disease. Despite these exorbitant numbers, the introduction of highly active antiretroviral therapy has marked a new era, changing the epidemiological profile of the infection and related pathologies, including neoplasms. Objective We performed a literature review to assess the role of neoplasms in patients with HIV after the introduction of antiretroviral therapy. Methods A literature review was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) method, searching the MEDLINE, LILACS, and COCHRANE databases for articles published from 2010 onwards. Results Using specific key terms, 1,341 articles were identified; two were duplicates, 107 were selected for full-text evaluation, and 20 were included in the meta-analysis. The selected studies included 2,605,869 patients. Fifteen of the 20 articles indicated a reduction in the global incidence of AIDS-defining neoplasms and 12 indicated an overall increase in non-AIDS-defining cancers after the introduction of antiretrovirals. This growth trend could be explained by a range of factors including the aging population with HIV, risky behaviors, and coinfection with oncogenic viruses. Conclusions There was a decreasing trend in the incidence of AIDS-defining neoplasms and increasing trend in non-AIDS-defining neoplasms. However, the carcinogenic effect of antiretrovirals could not be confirmed. In addition, studies focusing on the oncogenic role of HIV and screening for neoplasms in individuals with HIV are required.

16.
Einstein (São Paulo, Online) ; 21: eAO0156, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1440073

ABSTRACT

ABSTRACT Objective To compare viral suppression in treatment-naïve adults starting antiretroviral therapy with dolutegravir (50mg)- and efavirenz (600mg)-based regimens. Methods We analyzed secondary data from Brazilian health information systems of people living with human immunodeficiency virus who started antiretroviral therapy between 2015 and 2017 in Minas Gerais, Brazil. The outcome was viral suppression, defined as the achievement of the first viral load <50 copies/mL within 12 months after initiating antiretroviral therapy. This outcome was also compared with viral load <1,000 copies/mL and analyzed in two scenarios: intention-to-treat versus per-protocol. Time to viral suppression and adjusted odds ratio accompanied by 95% confidence intervals were estimated. Results Of the 2,599 participants enrolled, 77.5% were men, and the median age was 34 years. In the intention-to-treat analysis, viral suppression was 58.1% for efavirenz and 76.7% for dolutegravir. People living with HIV on dolutegravir-based regimen were more likely to achieve viral suppression (aOR: 2.44; 95%CI: 2.01-2.95) and had a shorter median time to viral suppression (p<0.0001). Antiretroviral therapy initiation within <120 days, baseline CD4⁺T-cells ≥200 cells/mm3, and viral load <100,000 copies/mL had higher odds of viral suppression. According to the per-protocol analysis, viral suppression ≥90% was observed by considering viral load <1,000 copies/mL. Conclusion Our study demonstrated that viral suppression improved after introducing dolutegravir, although the proportion of patients with viral load <50 copies/mL was lower than expected. Improved access to routine viral load examinations and continuous surveillance of the effectiveness of antiretroviral therapy should be considered.

17.
Rev. med. hered ; 33(4)dic. 2022.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1424210

ABSTRACT

Objetivos: Determinar la validez de la evaluación de consumo de alcohol realizado en la Estrategia Nacional de Salud para la Prevención y Control de ITS-VIH / SIDA (ESNITSS) a pacientes con VIH que iniciaron tratamiento antirretroviral (TARV). Material y métodos: El tipo de estudio fue de evaluación de prueba diagnóstica en pacientes en TARV de un hospital del Ministerio de Salud (MINSA), entre septiembre de 2017 y enero de 2018; en base al análisis de datos de la Fase I del estudio "Efectividad de la Consejería en Enfermería en la Mejora de la Adherencia al TARV en pacientes con VIH y Conducta de Consumo de Alcohol". 4000 pacientes conformaron la población de estudio y 350 pacientes fueron seleccionados aleatoriamente. Se procedió a la validación de la evaluación del consumo de alcohol realizado por la ESNITSS con dos Gold estándar: i. la evaluación del consumo de alcohol en el último mes y ii. el consumo de riesgo identificado con el Alcohol Use Disorders Identification Test (AUDIT). Se calculó sensibilidad, especificidad, seguridad de la evaluación y razones de probabilidad. Resultados: La sensibilidad y especificidad fue regular para la evaluación de consumo de alcohol en el último mes (S=0,64, E=0,57), la especificidad fue mala para la evaluación de consumo de riesgo (E=0,48). Las razones de verosimilitud positivas demuestraron que la evaluación no tiene utilidad diagnóstica para ninguno de los casos (<2). Conclusiones: La evaluación de "consumo actual de alcohol" realizada por la ESNITSS no mostró utilidad diagnóstica.


SUMMARY Objectives: To determine the validity of the evaluation of alcohol consumption established by the national strategy to prevent and control STI-HIV-AIDS (ESNITSS) of HIV-infected adults that started anti-retroviral treatment (ART). Methods: Diagnostic study of HIV patients in a single hospital in Lima from September 2017 to January 2018 using data from a phase one study "Effectiveness of nursing counseling in improving adherence to ART among patient with alcohol consumption". Three hundred and fifty patients were randomly selected among 4000 participants. Two gold standards evaluated alcohol consumption: 1. Last month alcohol consumption and ii; alcohol consumption identified by the Alcohol Use Disorders Identification Test (AUDIT). Sensitivity, specificity, safety of the evaluation and probability rates. Results: sensitivity and specificity were moderate for last month alcohol consumption (s=0.64; e=0.57); specificity was low for evaluation of consumption risk (e=0.48). Positive validity rates demonstrated that the evaluation is not useful (<2). Conclusions: The evaluation of alcohol consumption followed by the ESNITSS has no diagnostic utility.

18.
Saúde debate ; 46(spe5): 164-177, out.-dez. 2022. tab, graf
Article in Portuguese | LILACS-Express | LILACS | ID: biblio-1424561

ABSTRACT

RESUMO A terapia antirretroviral interfere na replicação do vírus HIV, impede a progressão da infecção para a Aids e previne a mortalidade precoce das crianças infectadas. Esta pesquisa investigou o perfil sociodemográfico e os parâmetros relacionados com o tratamento antirretroviral das crianças HIV positivas residentes no estado do Paraná. Trata-se de um estudo observacional descritivo e analítico realizado com dados secundários do ano de 2020 referentes às crianças com até 12 anos de idade. Foram investigados: perfil, prevalência, medicamentos em uso, abandono da terapia, resistência e supressão viral. Foram identificadas 148 crianças, com uma prevalência igual a 8,1/100 mil no Paraná. Apesar de todas as crianças diagnosticadas com HIV terem iniciado o tratamento, 17,2% encontravam-se em abandono da terapia antirretroviral. Entre as crianças que permaneciam em tratamento, 9,8% não atingiram a supressão viral e suas cargas virais comumente ultrapassavam mil cópias virais/mL. Houve um predomínio de esquemas medicamentosos provavelmente prescritos após falhas terapêuticas. Os resultados indicam que o Paraná apresenta bons resultados quanto ao início rápido da terapia e à supressão viral das crianças. Entretanto, existe um número considerável de abandonos da terapia e de falhas terapêuticas, indicando a necessidade de reforçar a vinculação desta população aos serviços de saúde.


ABSTRACT Antiretroviral therapy interferes with the replication of the HIV virus, stops the progression of infection, and prevents early mortality in infected children. This research investigated the sociodemographic profile and parameters related to the antiretroviral treatment of HIV positive children living in the state of Paraná. This is a descriptive observational and analytical study, carried out with secondary data from the year 2020, referring to children up to 12 years of age. The profile, prevalence, medicines in use, treatment abandonment, viral resistance, and viral suppression were investigated. A total of 148 children were identified, with a prevalence equal to 8.1/100,000 in Paraná. All infants had begun their treatment, but 17,2% abandoned it. Among children who remained on treatment, 9.8% did not achieve viral suppression and their viral loads commonly exceeded 1000 viral copies/mL. There was a predominance of drug regimens probably prescribed after treatment failures. The results indicate that Paraná presents good results in terms of rapid initiation of therapy and viral suppression in children. However, there is a considerable number of abandonments of therapy and therapeutic failures, indicating the need to strengthen the link between this population and health services.

19.
Rev. Enferm. UERJ (Online) ; 30: e62288, jan. -dez. 2022.
Article in English, Portuguese | LILACS-Express | LILACS | ID: biblio-1392588

ABSTRACT

Objetivo: analisar a associação da adesão à terapia antirretroviral em adultos com HIV/Aids e as dimensões das vulnerabilidades. Métodos: estudo quantitativo, com 230 pacientes de serviço especializado, por meio de questionários de avaliação da adesão ao tratamento, com dados submetidos à análise estatística inferencial. Resultados: dos pacientes, 44,3% apresentaram boa/adequada adesão com elementos da vulnerabilidade individual: apoio para conversar/desabafar sobre o problema de saúde (p=0,002); apoio para se divertir ou fazer atividade de lazer (p=0,000); e deixar de tomar a medicação devido à alteração na prescrição médica (p=0,018); social: sexo (p=0,005); nível de instrução (p=0,010); renda familiar (p=0,034); e condição empregatícia (p=0,007); e programática: acesso ao serviço (p=0,005); recebimento de informações (p=0,039); comunicação com os profissionais (p=0,024); educação em saúde (p=0,013); e deixar de tomar a medicação por não tê-la (p=0,039). Conclusão: a adesão foi classificada como boa/adequada e apontam-se elementos de vulnerabilidades que fragilizam ou potencializam a adesão.


Objective: to examine how adherence to antiretroviral therapy among adults with HIV/Aids associated with dimensions of vulnerability. Methods: this quantitative study of 230 patients in a specialized service used questionnaires to assess adherence to treatment. The resulting data were submitted to inferential analysis. Results: adherence was good/adequate in 44.3% of patients and associated with elements of vulnerability, which could be individual: support to talk or vent about the health problem (p = 0.002), support for fun or leisure activities (p = 0.000), and for not taking medication due to a change in medical prescription (p = 0.018); social: sex (p = 0.005); education level (p = 0.010), family income (p = 0.034), and employment status (p = 0.007); or program-related: access to the service (p = 0.005), receiving information (p = 0.039), communication with professionals (p = 0.024), health education (p = 0.013), and not taking medication for not having them (p = 0.039). Conclusion: Adherence was classified as good or adequate, and pointed to elements of vulnerability that weaken or strengthen adherence.


Objetivo: analizar la asociación de la adherencia a la terapia antirretroviral en adultos con VIH/SIDA y las dimensiones de las vulnerabilidades. Métodos: estudio cuantitativo, junto a 230 pacientes de servicios especializados, mediante cuestionarios para evaluar la adherencia al tratamiento, cuyos datos se sometieron al análisis estadístico inferencial. Resultados: el 44,3% de los pacientes tuvo buena / adecuada adherencia con elementos de vulnerabilidad individual: apoyo para hablar o desahogarse sobre el problema de salud (p = 0,002); apoyo para divertirse o realizar actividades de ocio (p = 0,000) y no tomar medicación por cambio de prescripción médica (p = 0,018); social: sexo (p = 0,005); nivel educativo (p = 0,010); ingresos familiares (p = 0,034) y situación laboral (p = 0,007); y programática: acceso al servicio (p = 0,005); recibir información (p = 0.039); comunicación con profesionales (p = 0,024); educación en salud (p = 0,013) y no tomar medicamentos por no tenerlos (p = 0,039). Conclusión: La adherencia se clasificó como buena / adecuada y se señalan elementos de vulnerabilidades que debilitan o mejoran la adherencia.

20.
Hematol., Transfus. Cell Ther. (Impr.) ; 44(3): 307-313, July-Sept. 2022. tab
Article in English | LILACS | ID: biblio-1404986

ABSTRACT

ABSTRACT Introduction: Hematologic abnormalities are common in HIV and involve all blood cell lineages. A study on cytopenias, as correlated with disease progression, can be valuable in resource-limited settings. This study aimed to determine the hematologic profile of HIV patients and its association with CD4 count and antiretroviral (ARV) treatment. Methods: This is a retrospective cohort study involving adult Filipino HIV patients with complete blood count (CBC) and CD4 count determinations prior to the initiation of ARV treatment and after ≥6 months of ARV treatment. Logistic regression was performed to determine the association between cytopenias and a CD4 count <200 cells/μL. Results: The study included 302 patients. Anemia was the most common cytopenia. Anemia and leukopenia were associated with an increased likelihood of having a CD4 count <200 cells/μL in ARV-naïve patients. In ARV-treated patients, leukopenia was associated with an increased probability of having a CD4 count <200 cells/μL. An increase in hemoglobin, white blood cell (WBC) and platelet counts was observed after ≥6 months of ARV treatment. Conclusion: Anemia and leukopenia can be used as markers of immune status in HIV-infected individuals and improvement in the CBC parameters can be used to assess response to ARV treatment. Routine monitoring of hematologic parameters is recommended.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , HIV Infections , Antiretroviral Therapy, Highly Active , Leukopenia , CD4 Antigens , Anemia
SELECTION OF CITATIONS
SEARCH DETAIL